Press "Enter" to skip to content

New patent for Hisamitsu drug SECUADO

2
Copyright © DrugPatentWatch. Originally published at New patent for Hisamitsu drug SECUADO

Annual Drug Patent Expirations for SECUADO
Annual Drug Patent Expirations for SECUADO

Secuado is a drug marketed by Hisamitsu and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

This drug has thirty-four patent family members in nine countries.

The generic ingredient in SECUADO is asenapine. One supplier is listed for this compound. Additional details are available on the asenapine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Hisamitsu drug SECUADO

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!